术前栓塞对组织学非富血供脊柱转移瘤手术结局的影响:倾向评分匹配研究
本研究回顾性纳入2018年1月至2022年12月接受手术的152例非富血供胸腰段脊柱转移瘤患者,经倾向评分匹配形成55对(110例)有或无术前栓塞(PrE)的配对。匹配后PrE组总体估计失血量(EBL)中位数600 mL低于非PrE组的900 mL(p=0.02),大量失血(≥2500 mL)发生率亦更低(5.5% vs 18.2%,p=0.03;OR 0.26,95%CI 0.06-0.91)。
要点
- 非富血供脊柱转移瘤术前栓塞可降低总体估计失血量。
- PrE组大量失血(≥2500 mL)发生率更低,OR 0.26(95%CI 0.06-0.91)。
- CT-DSA高强化或高侵袭性手术患者从PrE中获益更明显。
核心结论
- 在调整临床人口学因素后,PrE与非富血供胸腰段脊柱转移瘤患者估计失血量降低相关。
- 影像学高强化或接受高侵袭性手术的患者接受PrE在减少大量失血方面可能获益更大。
研究设计与样本
- 回顾性研究,纳入2018年1月至2022年12月接受手术的152例非富血供胸腰段脊柱转移瘤患者。
- 采用倾向评分匹配平衡手术指征与临床人口学特征,形成55对(110例)有或无PrE的匹配队列。
- 比较总体EBL、围手术期输血、手术时间、再手术率、大量失血(≥2500 mL)及30天和90天死亡率,并进行预设亚组分析。
主要发现
- 匹配PrE组总体EBL中位数600(IQR 300-1200)mL,低于非PrE组的900(IQR 500-1800)mL(p=0.02)。
- 大量失血发生率PrE组3例(5.5%),非PrE组10例(18.2%)(p=0.03;OR 0.26,95%CI 0.06-0.91)。
- 围手术期输血、手术时间、再手术率、30天死亡率及90天死亡率组间均无显著差异。
- 发生1例PrE相关脊髓梗死。
- 亚组分析显示,术前CT-DSA高强化患者及接受高侵袭性手术患者中PrE减少大量失血更有效(pinteraction分别为0.02和0.03)。
关键数值与推荐
- 大量失血定义为估计失血量≥2500 mL。
- PrE组大量失血OR 0.26(95%CI 0.06-0.91),p=0.03。
- 总体EBL组间比较p=0.02。
- 亚组交互作用p值:CT-DSA高强化pinteraction=0.02,高侵袭性手术pinteraction=0.03。
临床怎么用
- 对非富血供胸腰段脊柱转移瘤拟行手术者,可考虑术前栓塞以减少术中失血。
- 影像学CT-DSA高强化或计划高侵袭性手术的患者,PrE减少大量失血的潜在获益可能更大。
- PrE存在脊髓梗死等风险,需个体化权衡后决策。
局限性
- 本研究为回顾性设计。
- 匹配后样本量为55对(110例),规模有限。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: While preoperative embolization (PrE) is known to reduce blood loss during spinal surgery for histopathologically hypervascular metastases, its efficacy in nonhypervascular spinal metastases remains underexplored. This study aimed to evaluate the effectiveness of PrE in patients with nonhypervascular spinal metastatic tumors, focusing primarily on estimated blood loss (EBL) and secondarily on perioperative outcomes. METHODS: This retrospective study included 152 patients diagnosed with nonhypervascular thoracolumbar spinal metastases who underwent surgery between January 2018 and December 2022. Propensity score matching was performed to balance surgical indications and clinicodemographic characteristics, resulting in 55 matched pairs (110 patients) with or without PrE. Surgical outcomes (overall EBL, perioperative blood transfusion, operation time, reoperation rate, massive EBL [defined as ≥ 2500 mL], and 30- and 90-day mortality) were compared. Prespecified subgroup analyses were also conducted. RESULTS: The matched PrE group had significantly lower overall EBL (median 600 [IQR 300-1200] mL) compared with the matched non-PrE group (median 900 [IQR 500-1800] mL) (p = 0.02). The incidence of massive EBL was also lower in the PrE group (3 patients [5.5%]) than in the non-PrE group (10 patients [18.2%], p = 0.03; OR 0.26 [95% CI 0.06-0.91]). No significant differences were observed between groups regarding perioperative transfusion, operation time, reoperation rate, 30-day mortality, or 90-day mortality. However, 1 case of PrE-related spinal cord infarction occurred. Subgroup analyses revealed that PrE was more effective in reducing massive EBL among patients with hyperenhancement on preoperative CT-digital subtraction angiography and those undergoing highly invasive surgery (pinteraction = 0.02 and 0.03, respectively). CONCLUSIONS: After adjusting for clinicodemographic factors, PrE was associated with reduced EBL in patients with nonhypervascular thoracolumbar spinal metastases. Moreover, patients with radiological hyperenhancement or undergoing highly invasive surgery may derive greater benefit from PrE in mitigating massive EBL.
引用
- Liao TW, Huang YC, Lin YH, et al. Effects of preoperative embolization on outcomes in histopathologically nonhypervascular spinal metastases: a propensity score-matched study. J Neurosurg Spine. 2025. PMID: 41105979. doi:10.3171/2025.6.SPINE25223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。